Home > Healthcare > Pharmaceuticals > Finished Drug Form > aesthetic injectables market
Get a free sample of Aesthetic Injectables Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Aesthetic Injectables Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The aesthetic injectables industry is dynamic and competitive, driven by a combination of innovation, strategic collaborations, global expansion efforts, and a commitment to regulatory compliance. Companies such as Allergan (now part of AbbVie), Galderma, and Merz Pharma are notable players, with well-established product portfolios that include popular dermal fillers and botulinum toxin products.
Prominent players operating in the aesthetic injectables industry include:
The botulinum toxin segment is expected to reach USD 16.8 billion by 2032 owing to its high effectiveness in address dynamic wrinkles and fine lines of facial expressions.
The global market size for aesthetic injectables was valued at USD 13.2 billion in 2023 and is anticipated to showcase 10.2% CAGR through 2032 owing to the increasing aging population seeking non-surgical solutions for signs of aging, and rising beauty consciousness across age groups.
North America market for aesthetic injectables accounted for USD 7.5 billion in 2023 and is projected to reach USD 16.5 billion by 2032 attributed to the well-established and advanced healthcare infrastructure, including numerous dermatology clinics, medical spas, and aesthetic centers.
Who are the key players in the global aesthetic injectables industry?